A coalition of Vermont doctors is urging state lawmakers to cap the amount of THC allowed in all cannabis products at 15%, a move that, if implemented could have major ramifications for marijuana companies in the state.
According to VTDigger, the Vermont Medical Society – which represents 2,400 doctors and physician assistants – sent a resolution to the Legislature asking the state Cannabis Control Board to establish a new potency cap for the sake of consumer safety.
The physicians’ resolution also:
- Calls for health warnings to be mandated on cannabis product packaging and ads.
- Cited the state health department, which reported last year that “marijuana use is a significant public health problem in Vermont, and it is getting worse.”
It’s not clear yet whether regulators or lawmakers will act on the resolution.
Vermont already has a potency cap for its upcoming recreational marijuana market, with flower capped at 30% THC and concentrates at 60% THC.
Medical marijuana products in Vermont, however, are not limited on potency.
The learning curve for entering the cannabis industry is steep. Start with the fundamentals.
MJBiz Cannabis 101 Email Course
A 10-part email course designed to educate new hires and aspiring professionals on the key fundamental areas of the legal cannabis industry, including:
- History of legal cannabis in America
- Overview of plant-touching + ancillary business sectors
- Cannabis finance and investing
- Cannabis marketing and brand building
- Employment + hiring opportunities
- And much more!
Gain a comprehensive understanding of this complex industry with this free resource.
Vermont currently is the only state in the nation with THC potency limits, though lawmakers in Colorado and other states have been weighing such caps.
The new adult-use market in Vermont is expected to launch next spring.
